Topiramate for the treatment of neonatal seizures

Pediatric Neurology

Volumn 44, Issue 6, 2011, Pages 439-442

  Glass, Hannah C ^a   Poulin, Chantal ^b,c   Shevell, Michael I ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; TOPIRAMATE;

ABSENCE OF SIDE EFFECTS; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MEDICAL RECORD REVIEW; NEONATAL SEIZURE; NEUROPROTECTION; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE;

AGE FACTORS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; INFANT, NEWBORN; MALE; PATIENT ADMISSION; PATIENT DISCHARGE; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME;

EID: 79955846907     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2011.01.006     Document Type: Article

References (42)

1. Lanska MJ, Lanska D, Baumann R, Kryscio RJ. A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology 1995;45:724-32.
2. Ronen GM, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: A population-based study. J Pediatr 1999;134:71-5. (Pubitemid 29048682)
3. Lanska MJ, Lanska DJ. Neonatal seizures in the United States: Results of the National Hospital Discharge Survey, 1980-1991. Neuroepidemiology 1996;15:117-25.
4. Saliba RM, Annegers J, Waller D, Tyson J, Mizrahi EM. Incidence of neonatal seizures in Harris County, Texas, 1992-1994. Am J Epidemiol 1999;150:763-9.
5. Minchom P, Niswander K, Chalmers I, et al. Antecedents and outcome of very early neonatal seizures in infants born at or after term. Br J Obstet Gynaecol 1987;94:431-9. (Pubitemid 17068092)
6. Patterson CA, Graves W, Bugg G, Sasso S, Brann AW Jr. Antenatal and intrapartum factors associated with the occurrence of seizures in term infant. Obstet Gynecol 1989;74:361-5. (Pubitemid 19213923)
7. Glass HC, Pham T, Danielsen B, Towner D, Glidden D, Wu YW. Antenatal and intrapartum risk factors for seizures in term newborns: A population-based study, California 1998-2002. J Pediatr 2008;154:24-8.e1.
8. Volpe JJ. Neonatal seizures. In: Volpe JJ, editor. Neonatal neurology. Philadelphia: W.B. Saunders, 2008:203-44.
9. Glass HC, Glidden D, Jeremy RJ, Barkovich AJ, Ferriero DM, Miller SP. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr 2009;155:318-23.
10. Miller SP,Weiss J, Barnwell A, et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology 2002;58:542-8. (Pubitemid 34164934)
11. Holmes GL. The long-term effects of neonatal seizures. Clin Perinatol 2009;36:901-14.
12. Bartha AI, Shen J, Katz KH, et al. Neonatal seizures: Multicenter variability in current treatment practices. Pediatr Neurol 2007;37:85-90. (Pubitemid 47187647)
13. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007;9:353-412. (Pubitemid 351147653)
14. Bassan H, Bental Y, Shany E, et al. Neonatal seizures: Dilemmas in workup and management. Pediatr Neurol 2008;38:415-21. (Pubitemid 351681940)
15. Painter MJ, Scher M, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999;341:485-9. (Pubitemid 29372888)
16. Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089-94. (Pubitemid 35334614)
17. Forcelli PA, Janssen M, Stamps L, Sweeney C, Vicini S, Gale K. Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure. Epilepsia 2010;51(Suppl. 3):18-23.
18. Schubert S, Brandl U, Brodhun M, et al. Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res 2005;1058:129-36. (Pubitemid 41416807)
19. Liu Y, Barks J, Xu G, Silverstein FS. Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 2004;35:1460-5. (Pubitemid 38697476)
20. Koh S, Tibayan F, Simpson JN, Jensen FE. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 2004;45:569-75. (Pubitemid 38802202)
21. Zhao Q, Hu Y, Holmes GL. Effect of topiramate on cognitive function and activity level following neonatal seizures. Epilepsy Behav 2005;6:529-36. (Pubitemid 40674278)
22. Cha BH, Silveira D, Liu X, Hu Y, Holmes GL. Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res 2002;51:217-32. (Pubitemid 35232568)
23. Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C. Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 2004;187:403-9. (Pubitemid 38610286)
24. Silverstein FS, Ferriero DM. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol 2008;39:77-9. (Pubitemid 351970659)
25. Mizrahi EM, Kellaway P. Characterization and classification of neonatal seizures. Neurology 1987;37:1837-44. (Pubitemid 18026362)
26. Alaverdashvili M, Kubova H, Mares P. Motor performance and behavior of immature rats are not compromised by a high dose of topiramate. Epilepsy Behav 2005;7:222-30. (Pubitemid 41149524)
27. Perry MS, Holt P, Sladky JT. Topiramate loading for refractory status epilepticus in children. Epilepsia 2006;47:1070-1. (Pubitemid 43801519)
28. Kahriman M, Minecan D, Kutluay E, Selwa L, Beydoun A. Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 2003;44:1353-6. (Pubitemid 37280381)
29. Veggiotti P, Longaretti F, Signorini S, Cardinali S, Lanzi G. Topiramate efficacy in an infant with partial seizures refractory to conventional antiepileptic drugs. Seizure 2004;13:241-3. (Pubitemid 38607550)
30. Valencia I, Fons C, Kothare S, et al. Efficacy and tolerability of topiramate in children younger than 2 years old. J Child Neurol 2005;20:667-9.
31. Kim JM, Kwon S, Seo H, Choe B, Cho M, Park SP. Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-up. J Korean Med Sci 2009;24:1078-82.
32. Grosso S, Galimberti D, Farnetani MA, et al. Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure 2005;14:183-9. (Pubitemid 40425267)
33. Hsieh MY, Lin K, Wang H, Chou M, Hung P, Chang MY. Lowdose topiramate is effective in the treatment of infantile spasms. Chang Gung Med J 2006;29:291-6. (Pubitemid 44140241)
34. Peltzer B, Alonso WD, Porter BE. Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms. J Child Neurol 2009;24:400-5.
35. Kwon YS, Jun Y, Hong Y, Son BK. Topiramate monotherapy in infantile spasm. Yonsei Med J 2006;47:498-504. (Pubitemid 44322976)
36. Zou LP, Lin Q, Qin J, Cai F, Liu Z, Mix E. Evaluation of openlabel topiramate as primary or adjunctive therapy in infantile spasms. Clin Neuropharmacol 2008;31:86-92. (Pubitemid 351489334)
37. Watemberg N, Goldberg-Stern H, Ben-Zeev B, et al. Clinical experience with open-label topiramate use in infants younger than 2 years of age. J Child Neurol 2003;18:258-62. (Pubitemid 36603623)
38. Novotny E, Renfroe B, Yardi N, et al. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology 2010;74:714-20.
39. Murray DM, Boylan G, Ali I, Ryan CA, Murphy B, Connolly S. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 2008;93:F187-91.
40. Malone A, Ryan C, Fitzgerald A, Burgoyne L, Connolly S, Boylan GB. Interobserver agreement in neonatal seizure identification. Epilepsia 2009;50:2097-101.
41. Silverstein FS, Jensen FE, Inder T, Hellstrom-Westas L, Hirtz D, Ferriero DM. Improving the treatment of neonatal seizures: National Institute of Neurological Disorders and Stroke Workshop report. J Pediatr 2008;153:12-5.
42. Kriel R, Clark A, Leppik I, Marino S, Brundage R, Cloyd J. Pharmacokinetics and safety of oral and intravenous topiramate in adult volunteers. American Epilepsy Society abstract #1.285, 2010. Available at: http://www.aesnet.org/go/publications/aes-abstracts/abstract-search/ mode/display/st/topiramate%20and%20intravenous/sy/2010/sb/All/id/12485